ArticleFrontiers in medicine2022

Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinoma.

Jan-Mou Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.